Duale: Digital tools will help in weeding out counterfeit drugs, quacks
National
By
Patrick Beja
| Nov 17, 2025
Health Cabinet Secretary Aden Duale has said that Kenya will use technology to weed out quacks and counterfeit medicines in the market.
He said Kenya is tightening governance of procurement, track-and-trace, and anti-counterfeit systems so that every shipment is verifiable from production line to patient.
He said transparent, digital, end-to-end visibility protects patients, reassures investors, and makes public finance count twice. He said digitisation has helped curb fake drugs and counterfeits in the country.
Addressing the 7th biennial Scientific Conference on Medical Product Regulation in Africa held in Mombasa yesterday, Duale said Kenya had strengthened governance to curb counterfeits.
“We are cultivating technology-transfer hubs, incentivising backward integration for inputs, and building the power, logistics, and skills base manufacturers require to compete—first in the continent then globally,” he said.
READ MORE
Why every Kenyan must protect their personal data
AG's office in the spot for hindering KenGen's cheaper power plan
Pesalink, PAPSS deal cuts currency barriers for Kenya cross-border payments
Manyanja Mall: Quickmart, Goodlife and Rubis among anchor tenants of Sh400 million mall
Econetix inaugural CORSIA deal channels carbon finance to Africa
Industry leaders push to accelerate social governance in brokerage
VAT reforms: Why manufacturers want tax cuts
Inside Nyakang'o's trouble with Infrastructure Fund Bill
Kenya has urged other African nations to join a new continental regulatory body for medical products to guarantee access to the Africa Continental Free Trade Area (AfCFTA), saying the transition has provided certainty on product standards.
Duale told other states to ratify, resource and operationalise the Africa Medicines Agency (AMA) to ensure common standards for medical products in the region.
The 55 African Union member states are expected to use AMA to promote common standards for medicines and medical products and encourage local manufacturing of the products.
Participants noted that when standards converge, there will be increased investment, job creation and technology transfer on the continent.